Compounds > organophosphonates
Page last updated: 2024-09-05

organophosphonates and Central Nervous System Diseases

organophosphonates has been researched along with Central Nervous System Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chinthapalli, S; Mandalia, S; Martin, T; Nelson, M; Scourfield, A; Waters, L; Zheng, J1
Bell, DM; Casey, CG; Cono, J1
Drew, WL; Lalezari, JP1

Reviews

1 review(s) available for organophosphonates and Central Nervous System Diseases

ArticleYear
Cytomegalovirus: disease syndromes and treatment.
    Current clinical topics in infectious diseases, 1999, Volume: 19

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Central Nervous System Diseases; Chorioretinitis; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds; Pneumonia; Sexually Transmitted Diseases, Viral

1999

Other Studies

3 other study(ies) available for organophosphonates and Central Nervous System Diseases

ArticleYear
Discontinuation of Atripla as first-line therapy in HIV-1 infected individuals.
    AIDS (London, England), 2012, Jul-17, Volume: 26, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; California; Central Nervous System Diseases; Cohort Studies; Deoxycytidine; Depression; Dreams; Drug Combinations; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Humans; Male; New Jersey; Organophosphonates; Oxazines; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Sleep Initiation and Maintenance Disorders

2012
Smallpox vaccination and adverse reactions. Guidance for clinicians.
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2003, Feb-21, Volume: 52, Issue:RR-4

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Antiviral Agents; Central Nervous System Diseases; Child; Child, Preschool; Cidofovir; Contraindications; Cross Infection; Cytosine; Disease Transmission, Infectious; Drugs, Investigational; Eye Infections; Female; Fetal Diseases; Humans; Hypersensitivity; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Tests; Infant; Infection Control; Infectious Disease Transmission, Vertical; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pregnancy; Risk Factors; Skin Diseases, Eczematous; Skin Diseases, Vesiculobullous; Smallpox Vaccine; Vaccination; Vaccinia

2003
Three new drugs for HIV infection.
    The Medical letter on drugs and therapeutics, 1998, Dec-04, Volume: 40, Issue:1041

    Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Dideoxynucleosides; Dizziness; Drug Therapy, Combination; Headache; HIV Infections; Humans; Organophosphonates; Oxazines; Reverse Transcriptase Inhibitors

1998